| |
| |
|
| Insider
Information: |
Renaud Ronald C Jr |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
380,969 |
|
|
Indirect Shares
|
83,857 |
|
|
| Direct
Value |
$6,842,831 |
|
|
|
Indirect Value
|
$3,561,407 |
|
|
| Total
Shares |
464,826 |
|
|
| Total
Value |
$10,404,238 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 76.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2007-02-14 |
94,027 |
|
0 |
Premium* |
|
|
Idenix Pharmaceuticals Inc |
IDIX |
President & CEO, Direc... |
2014-06-19 |
89,990 |
2008-03-11 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
Director |
2014-12-02 |
5,000 |
2014-12-02 |
0 |
Premium* |
|
|
Translate Bio, Inc. |
TBIO |
Chief Executive Office... |
2021-09-14 |
0 |
2021-09-14 |
0 |
Premium* |
|
|
Atara Biotherapeutics, Inc. |
ATRA |
|
2022-06-23 |
31,500 |
2021-06-08 |
0 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
|
2023-12-19 |
160,452 |
2023-12-19 |
83,857 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CERE |
Cerevel Therapeutics Hold... |
President & CEO |
• • – |
2023-12-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
160,452 |
160,452 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
President & CEO |
• • – |
2023-08-03 |
4 |
B |
$23.96 |
$2,008,811 |
I/I |
83,857 |
83,857 |
0.01 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2022-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
20,500 |
31,500 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer |
• • – |
2021-09-14 |
4 |
S |
$38.00 |
$17,131,236 |
I/I |
(450,822) |
0 |
0 |
% |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer |
• • – |
2021-09-14 |
4 |
S |
$38.00 |
$19,122,778 |
D/D |
(503,231) |
0 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
|
• • – |
2021-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
11,000 |
11,000 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer |
• • – |
2021-04-07 |
4/A |
OE |
$7.39 |
$66,702 |
D/D |
9,026 |
503,231 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer |
• • – |
2021-04-07 |
4 |
OE |
$7.39 |
$66,702 |
D/D |
9,026 |
503,321 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer, Pres. |
• • – |
2021-01-14 |
4 |
OE |
$7.39 |
$41,673 |
D/D |
5,639 |
494,205 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
Chief Executive Officer, Pres. |
• • – |
2020-11-16 |
4 |
OE |
$7.39 |
$391,725 |
D/D |
53,007 |
488,566 |
0 |
- |
|
| TBIO |
Translate Bio, Inc. |
See Remarks |
• • – |
2018-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
81,818 |
40,909 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2014-12-02 |
4 |
B |
$11.92 |
$59,587 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President & CEO |
• • – |
2014-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
89,990 |
89,990 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President & CEO |
• • – |
2014-06-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,990 |
0 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
President & CEO |
• • – |
2012-12-14 |
4 |
OE |
$2.41 |
$199,976 |
D/D |
74,990 |
89,990 |
0 |
- |
|
| IDIX |
Idenix Pharmaceuticals In... |
Chief Financial Officer |
• – – |
2008-03-11 |
4 |
B |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
2.66 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2007-02-14 |
4 |
D |
$11.79 |
$70,422 |
D/D |
(5,973) |
94,027 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
SVP, CFO, Treasurer, Secretary |
• – – |
2006-02-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
